Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape

Amneal Pharmaceuticals Eyes Major Market Entry with Xolair Biosimilar, Pledging Affordable Relief

Novartis CEO Warns: Trump Tariffs Could Ignite Drug Price Surge and Stifle Innovation

Novartis Plots Strategic Price Adjustments in US as Trump's MFN Deadline Looms

The Future of Vision: Could Eye Drops Really Replace Your Reading Glasses?

India Delivers Major Blow to Novartis: Blockbuster Heart Drug Entresto Patent Revoked

Novartis Forges Monumental US$5.7 Billion Alliance with Monte Rosa Therapeutics to Revolutionize Drug Discovery